Literature DB >> 17237377

The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo.

Alessandra Polenghi1, Fleur Bossi, Fabio Fischetti, Paolo Durigutto, Anna Cabrelle, Nicola Tamassia, Marco A Cassatella, Cesare Montecucco, Francesco Tedesco, Marina de Bernard.   

Abstract

Helicobacter pylori induces an acute inflammatory response followed by a chronic infection of the human gastric mucosa characterized by infiltration of neutrophils/polymorphonuclear cells (PMNs) and mononuclear cells. The H. pylori neutrophil-activating protein (HP-NAP) activates PMNs, monocytes, and mast cells, and promotes PMN adherence to the endothelium in vitro. By using intravital microscopy analysis of rat mesenteric venules exposed to HP-NAP, we demonstrated, for the first time in vivo, that HP-NAP efficiently crosses the endothelium and promotes a rapid PMN adhesion. This HP-NAP-induced adhesion depends on the acquisition of a high affinity state of beta(2) integrin on the plasma membrane of PMNs, and this conformational change requires a functional p38 MAPK. We also show that HP-NAP stimulates human PMNs to synthesize and release a number of chemokines, including CXCL8, CCL3, and CCL4. Collectively, these data strongly support a central role for HP-NAP in the inflammation process in vivo: indeed, HP-NAP not only recruits leukocytes from the vascular lumen, but also stimulates them to produce messengers that may contribute to the maintenance of the flogosis associated with the H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237377     DOI: 10.4049/jimmunol.178.3.1312

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

Authors:  Ianko D Iankov; Iana H Haralambieva; Evanthia Galanis
Journal:  Vaccine       Date:  2010-12-21       Impact factor: 3.641

Review 2.  Dps-like proteins: structural and functional insights into a versatile protein family.

Authors:  Teemu Haikarainen; Anastassios C Papageorgiou
Journal:  Cell Mol Life Sci       Date:  2009-10-14       Impact factor: 9.261

3.  The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?

Authors:  Banu Kara; Hikmet Akkiz; Figen Doran; Suleyman Bayram; Eren Erken; Yuksel Gumurdullu; Macit Sandikci
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

Review 4.  Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer.

Authors:  Acacia Lamb; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2013-03       Impact factor: 4.429

5.  Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.

Authors:  Theodora Choli-Papadopoulou; Filippos Kottakis; Georgios Papadopoulos; Stefanos Pendas
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

6.  Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells.

Authors:  Chung-Che Tsai; Ting-Yu Kuo; Zhi-Wei Hong; Ying-Chieh Yeh; Kuo-Shun Shih; Shin-Yi Du; Hua-Wen Fu
Journal:  Virulence       Date:  2015-09-16       Impact factor: 5.882

Review 7.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

9.  Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease.

Authors:  V Koussoulas; S Vassiliou; E J Giamarellos-Bourboulis; G Tassias; A Kotsaki; C Barbatzas; M Tzivras
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

10.  Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.

Authors:  Min Long; Jun Luo; Yan Li; Fang-Yin Zeng; Ming Li
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.